ACT Oncology names Julia Amo as COO
ACT Oncology, a niche oncology service provider, has appointed Julia Amo, MBA, PMP, as chief operating officer.
In her new position, Amo will be responsible for leading strategic planning, implementation and business operations as she assists in developing the framework and infrastructure to support company growth.
Amo has over 20 years of leadership experience in the healthcare, pharmaceutical and CRO industries. Most recently she served as vice president of corporate strategic initiatives at PharmaNet/i3. Prior to that, she worked at Valeant Pharmaceuticals as vice president of business operations and project management and at Covance in senior level strategic and business operations positions.